No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 8 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Jin Medical International Ltd. (ZJYL) stock was $1.99 as of Oct 6, 2026, 4:00 PM EDT, up 0.51% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -82.9% · 3-year avg -56.1%/yr
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement.
Medical - Instruments & Supplies · Changzhou, JS
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.01
vs Estimate
N/A
Revenue
$8.92M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ZJYL | $15.58M | $1.99 | +0.51% | -82.93% | N/A | N/A | N/A |
| 2ALLR | $15.68M | $0.99 | -1.47% | -38.75% | N/A | N/A | vs ZJYL |
| 3BCDA | $15.78M | $1.06 | -2.75% | -19.72% | -61.39% | -46.74% | vs ZJYL |
| 4COCP | $15.30M | $1.11 | +0.00% | -8.23% | -37.50% | -39.76% | vs ZJYL |
| 5KTTA | $14.94M | $0.45 | -1.74% | -42.31% | -61.48% | N/A | vs ZJYL |
| 6KPTI | $14.73M | $0.65 | -3.07% | -89.38% | -62.18% | -41.85% | vs ZJYL |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$1.99
High
N/A
